CSIMarket
 
Northwest Biotherapeutics inc  (NWBO)
Other Ticker:  
 
 

Northwest Biotherapeutics Inc Balance Sheet Annual

NWBO


Select the Financial Report:   Period:   Fiscal Year:




NWBO Balance Sheets
(Annual, GAAP in millions $)

(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
ASSETS
Cash & cash equivalent 6.97 15.17 9.98 0.37 22.22
Restricted Cash and Investments, Current, Total - - - - -
Cash & Short-term Investments 6.97 15.17 9.98 0.37 22.22
Accounts receivable - - - - -
Other Receivables - - - - -
Notes Receivable, Current - - - - -
Inventories - - - - -
Other Current Assets - - - 0.00 -
Prepaid Expense And Other Assets Current 2.46 2.12 5.53 2.83 1.57
Total Current Assets 9.43 17.29 15.51 3.20 23.80
Equipment/Property/Plant Net 13.42 15.03 1.04 0.28 0.11
Goodwill net 0.63 0.63 0.63 - -
Intangible Assets 1.29 1.29 1.29 - -
Long-term investments - - - - -
Accounts Receivable, Net, Noncurrent - - - - -
Financial Instruments - - - - -
Tax Assets, Noncurrent - - - - -
Other Assets, Noncurrent 6.56 5.93 14.43 5.65 0.76
Deferred Finance Costs, Noncurrent, Net DE1 - - - - -
Discontinued operations, Noncurrent - - - - -
Total Assets 31.32 40.16 32.90 9.13 24.67
LIABILITIES
Accounts Payable and Accrued Liabilities, Current LI 10.69 6.98 7.38 6.35 15.51
Accrued Environmental Loss Contingencies, Current LI - - - - -
Derivative Liability, Current DE 80.56 106.78 354.97 20.21 30.00
Notes Payable, Current NO 15.40 7.10 2.44 5.50 7.16
Other Liabilities, Current 8.12 4.67 9.36 1.87 17.05
Taxes Payable - - - - -
Deferred Compensation Share-based Arrangements, Liability, Current DE1 2.57 - - - 0.14
Business Combination, Contingent Consideration, Liability, Current BU 8.67 8.23 8.28 7.26 -
Share Liability 6.96 0.32 0.17 - -
Operating Lease Liability Current 0.14 0.25 - - -
Convertible Notes At Fair Value Current - - - - -
Sale Leaseback Transaction Deferred Gain Net - - - - -
Total Current Liabilities 126.01 133.77 382.42 41.19 69.84
Long-term debt 5.99 25.16 8.51 6.59 1.99
Capital Lease and Other - - - - -
Convertible Notes Payable, Noncurrent LO - - - - -
Total Long-term Debt 5.99 25.16 8.51 6.59 1.99
Financial Instruments, Insurance, Noncurrent - - - - -
Employee Benefit Plans, Noncurrent - - - - -
Deferred credits, Noncurrent - - - - -
Accrued Income Taxes, Noncurrent - - - - -
Discontinued Operation, Liabilities, Noncurrent - - - - -
Other liabilities, Noncurrent 0.00 - - - -
Operating Lease Liability Noncurrent 4.37 5.23 4.92 4.91 -
Total Liabilities 136.37 164.15 395.85 52.70 71.83
SHAREHOLDER'S EQUITY
Common Stock Value 1.07 0.95 0.83 0.61 0.52
Common Stock, Held by Subsidiary Share, Subscribed but Unissued, Subscriptions Receivable -0.08 -0.08 -0.08 -0.01 -0.01
Additional Paid In Capital Common Stock 1,164.89 1,066.87 1,008.67 794.90 775.74
Retained Earnings / Accumulated Deficit -1,297.12 -1,192.09 -1,371.22 -839.91 -824.41
Other Equity -19.92 0.36 -1.15 0.84 1.00
Noncontrolling interests & other 23.06 - - - -
Total Stockholder's Equity -128.10 -123.99 -362.95 -43.57 -47.16
Liabilities & Stockholder's Equity 31.32 40.16 32.90 9.13 24.67






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com